Fresenius Stock Based Compensation from 2010 to 2026

FMS Stock

USD 24.44 0.02 0.08%

Fresenius Medical Stock Based Compensation yearly trend continues to be comparatively stable with very little volatility. Stock Based Compensation is likely to outpace its year average in 2026. Stock Based Compensation is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. View All Fundamentals

Stock Based Compensation

First Reported

2002-12-31

Previous Quarter

32.5 M

Current Value

38.5 M

Quarterly Volatility

56.4 M

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Interest Hikes

Check Fresenius Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Fresenius Medical's main balance sheet or income statement drivers, such as Interest Expense of 268.2 M, Total Revenue of 11.7 B or Gross Profit of 3.7 B, as well as many indicators such as Price To Sales Ratio of 1.47, Dividend Yield of 0.0123 or PTB Ratio of 0.96. Fresenius financial statements analysis is a perfect complement when working with Fresenius Medical Valuation or Volatility modules.

Build AI portfolio with Fresenius Stock

Check out the analysis of Fresenius Medical Correlation against competitors.

The evolution of Stock Based Compensation for Fresenius Medical Care provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Fresenius Medical compares to historical norms and industry peers.

Latest Fresenius Medical's Stock Based Compensation Growth Pattern

Below is the plot of the Stock Based Compensation of Fresenius Medical Care over the last few years. It is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. Fresenius Medical's Stock Based Compensation historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Fresenius Medical's overall financial position and show how it may be relating to other accounts over time.

Stock Based Compensation

10 Years Trend

Pretty Stable

Compare to Others All Fundamentals

Stock Based Compensation

Timeline

Fresenius Stock Based Compensation Regression Statistics

	Arithmetic Mean	(194,644,885)
	Coefficient Of Variation	(309.92)
	Mean Deviation	376,323,439
	Median	11,271,355
	Standard Deviation	603,244,012
	Sample Variance	363903.3T
	Range	1.9B
	R-Value	(0.18)
	Mean Square Error	376130.5T
	R-Squared	0.03
	Significance	0.50
	Slope	(21,033,157)
	Total Sum of Squares	5822453.4T

Fresenius Stock Based Compensation History

	2026	30.7 M
	2025	29.3 M
	2023	32.5 M
	2022	-5.9 M
	2021	-1.7 B
	2020	-1.9 B
	2019	2 M

Other Fundumenentals of Fresenius Medical Care

Stock Based Compensation To Revenue

Fresenius Medical Stock Based Compensation component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Current Deferred Revenue	Long Term Debt	Property Plant Equipment	Good Will	Short Term Investments	Net Tangible Assets	Long Term Investments	Short Long Term Debt	Treasury Stock	Long Term Debt Total	Capital Surpluse	Net Invested Capital	Cash And Equivalents	Net Working Capital	Capital Stock
Total Assets		0.8	0.94	0.83	0.79	0.87	0.99	0.97	0.67	-0.04	0.5	-0.12	0.44	0.82	0.92	0.63	0.04	0.56	-0.72	0.3	0.68	-0.69	0.32	0.01	0.39	-0.28
Total Stockholder Equity	0.8		0.69	0.99	0.98	0.68	0.76	0.79	0.5	-0.02	0.42	-0.23	0.29	0.89	0.87	0.6	-0.02	0.62	-0.77	0.23	0.65	-0.85	0.46	0.05	0.52	-0.75
Net Debt	0.94	0.69		0.74	0.68	0.79	0.97	0.84	0.65	0.01	0.4	-0.03	0.51	0.84	0.85	0.58	-0.1	0.43	-0.62	0.08	0.79	-0.67	0.22	-0.22	0.17	-0.23
Retained Earnings	0.83	0.99	0.74		0.98	0.73	0.81	0.82	0.54	-0.02	0.46	-0.18	0.33	0.9	0.91	0.66	-0.03	0.59	-0.81	0.27	0.66	-0.86	0.38	0.05	0.46	-0.7
Accounts Payable	0.79	0.98	0.68	0.98		0.74	0.75	0.79	0.49	-0.14	0.44	-0.2	0.36	0.84	0.89	0.64	-0.07	0.58	-0.78	0.29	0.58	-0.78	0.43	0.02	0.47	-0.71
Net Receivables	0.87	0.68	0.79	0.73	0.74		0.87	0.93	0.59	-0.42	0.53	0.1	0.59	0.58	0.88	0.67	-0.12	0.36	-0.74	0.49	0.35	-0.43	0.2	0.07	0.23	-0.11
Total Liab	0.99	0.76	0.97	0.81	0.75	0.87		0.93	0.68	-0.03	0.49	-0.05	0.48	0.83	0.91	0.64	-0.02	0.48	-0.71	0.24	0.72	-0.7	0.25	-0.06	0.28	-0.25
Total Current Assets	0.97	0.79	0.84	0.82	0.79	0.93	0.93		0.64	-0.21	0.52	-0.09	0.47	0.71	0.92	0.63	0.08	0.53	-0.74	0.44	0.51	-0.59	0.3	0.17	0.45	-0.22
Short Term Debt	0.67	0.5	0.65	0.54	0.49	0.59	0.68	0.64		0.03	0.13	-0.42	-0.02	0.61	0.62	0.28	0.41	-0.01	-0.39	0.48	0.37	-0.49	0.03	0.32	-0.14	-0.06
Intangible Assets	-0.04	-0.02	0.01	-0.02	-0.14	-0.42	-0.03	-0.21	0.03		-0.07	-0.34	-0.65	0.2	-0.14	0.01	0.05	0.16	0.01	-0.22	0.42	-0.32	0.09	-0.18	0.08	-0.2
Common Stock	0.5	0.42	0.4	0.46	0.44	0.53	0.49	0.52	0.13	-0.07		0.49	0.43	0.28	0.57	0.61	-0.22	0.24	-0.63	0.42	0.13	-0.23	0.13	0.07	0.13	-0.08
Current Deferred Revenue	-0.12	-0.23	-0.03	-0.18	-0.2	0.1	-0.05	-0.09	-0.42	-0.34	0.49		0.56	-0.25	-0.05	0.19	-0.56	-0.14	-0.07	-0.19	-0.21	0.3	-0.35	-0.1	-0.27	0.27
Long Term Debt	0.44	0.29	0.51	0.33	0.36	0.59	0.48	0.47	-0.02	-0.65	0.43	0.56		0.27	0.47	0.37	-0.37	0.15	-0.33	-0.12	0.21	-0.07	0.05	-0.23	0.06	-0.01
Property Plant Equipment	0.82	0.89	0.84	0.9	0.84	0.58	0.83	0.71	0.61	0.2	0.28	-0.25	0.27		0.81	0.5	0.01	0.5	-0.62	-0.01	0.89	-0.92	0.33	-0.14	0.3	-0.66
Good Will	0.92	0.87	0.85	0.91	0.89	0.88	0.91	0.92	0.62	-0.14	0.57	-0.05	0.47	0.81		0.71	-0.05	0.45	-0.84	0.4	0.58	-0.68	0.29	0.03	0.34	-0.37
Short Term Investments	0.63	0.6	0.58	0.66	0.64	0.67	0.64	0.63	0.28	0.01	0.61	0.19	0.37	0.5	0.71		-0.46	0.39	-0.79	0.3	0.42	-0.43	0.21	-0.04	0.21	-0.28
Net Tangible Assets	0.04	-0.02	-0.1	-0.03	-0.07	-0.12	-0.02	0.08	0.41	0.05	-0.22	-0.56	-0.37	0.01	-0.05	-0.46		-0.24	0.27	0.37	-0.16	-0.1	-0.01	0.63	0.07	0.14
Long Term Investments	0.56	0.62	0.43	0.59	0.58	0.36	0.48	0.53	-0.01	0.16	0.24	-0.14	0.15	0.5	0.45	0.39	-0.24		-0.45	-0.15	0.55	-0.5	0.54	-0.21	0.81	-0.53
Short Long Term Debt	-0.72	-0.77	-0.62	-0.81	-0.78	-0.74	-0.71	-0.74	-0.39	0.01	-0.63	-0.07	-0.33	-0.62	-0.84	-0.79	0.27	-0.45		-0.42	-0.4	0.59	-0.28	-0.03	-0.34	0.42
Treasury Stock	0.3	0.23	0.08	0.27	0.29	0.49	0.24	0.44	0.48	-0.22	0.42	-0.19	-0.12	-0.01	0.4	0.3	0.37	-0.15	-0.42		-0.34	-0.03	-0.02	0.52	0.01	0.19
Long Term Debt Total	0.68	0.65	0.79	0.66	0.58	0.35	0.72	0.51	0.37	0.42	0.13	-0.21	0.21	0.89	0.58	0.42	-0.16	0.55	-0.4	-0.34		-0.81	0.32	-0.43	0.31	-0.57
Capital Surpluse	-0.69	-0.85	-0.67	-0.86	-0.78	-0.43	-0.7	-0.59	-0.49	-0.32	-0.23	0.3	-0.07	-0.92	-0.68	-0.43	-0.1	-0.5	0.59	-0.03	-0.81		-0.21	0.04	-0.36	0.76
Net Invested Capital	0.32	0.46	0.22	0.38	0.43	0.2	0.25	0.3	0.03	0.09	0.13	-0.35	0.05	0.33	0.29	0.21	-0.01	0.54	-0.28	-0.02	0.32	-0.21		-0.15	0.62	-0.39
Cash And Equivalents	0.01	0.05	-0.22	0.05	0.02	0.07	-0.06	0.17	0.32	-0.18	0.07	-0.1	-0.23	-0.14	0.03	-0.04	0.63	-0.21	-0.03	0.52	-0.43	0.04	-0.15		0.05	0.13
Net Working Capital	0.39	0.52	0.17	0.46	0.47	0.23	0.28	0.45	-0.14	0.08	0.13	-0.27	0.06	0.3	0.34	0.21	0.07	0.81	-0.34	0.01	0.31	-0.36	0.62	0.05		-0.45
Capital Stock	-0.28	-0.75	-0.23	-0.7	-0.71	-0.11	-0.25	-0.22	-0.06	-0.2	-0.08	0.27	-0.01	-0.66	-0.37	-0.28	0.14	-0.53	0.42	0.19	-0.57	0.76	-0.39	0.13	-0.45

Click cells to compare fundamentals

About Fresenius Medical Financial Statements

Fresenius Medical shareholders use historical fundamental indicators, such as Stock Based Compensation, to determine how well the company is positioned to perform in the future. Although Fresenius Medical investors may analyze each financial statement separately, they are all interrelated. The changes in Fresenius Medical's assets and liabilities, for example, are also reflected in the revenues and expenses on on Fresenius Medical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

		Last Reported	Projected for Next Year
	Stock Based Compensation	29.3 M	30.7 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Fresenius Stock Analysis

When running Fresenius Medical's price analysis, check to measure Fresenius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fresenius Medical is operating at the current time. Most of Fresenius Medical's value examination focuses on studying past and present price action to predict the probability of Fresenius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fresenius Medical's price. Additionally, you may evaluate how the addition of Fresenius Medical to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC

Fresenius Stock Based Compensation from 2010 to 2026

Latest Fresenius Medical's Stock Based Compensation Growth Pattern

Fresenius Stock Based Compensation Regression Statistics

Fresenius Stock Based Compensation History

Other Fundumenentals of Fresenius Medical Care

Fresenius Medical Stock Based Compensation component correlations

About Fresenius Medical Financial Statements

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Fresenius Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY